Monoclonal antibody (mAb) glycoengineering has the potential to improve the efficacy of biopharmaceuticals by fine-tuning specific biological properties. Glycosylation analysis is key to monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results